Pooled Human BM-MSCs and Hyaluronic Acid Restore Disc Matrix Homeostasis and Histological Architecture in a Rat Disc Degeneration Model of Lower Back Pain
This study demonstrates that intradiscal injection of pooled human bone marrow-derived mesenchymal stromal cells combined with a hyaluronic acid hydrogel effectively restores intervertebral disc matrix homeostasis, reverses fibrotic degeneration, and alleviates lower back pain in a rat model of disc disease.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The human spine is a remarkable stack of bones, but between each vertebra lies a soft, cushion-like structure called an intervertebral disc. These discs act as shock absorbers, allowing the spine to bend and twist while protecting the nerves inside. Over time, or after an injury, these cushions can wear down. The gel-like center, which normally holds water to keep the disc plump and functional, begins to dry out and shrink. The cells that maintain this gel lose their ability to do their job, and the tissue often becomes stiff and scarred, a condition known as disc degeneration. This process is a leading cause of chronic lower back pain, a problem that affects millions of people and can severely limit daily life. While doctors have many ways to manage the pain, such as medication or surgery, few treatments actually stop the damage or help the disc heal itself. Scientists have been exploring whether living cells, specifically those known as mesenchymal stromal cells, could be used to repair these damaged discs, but creating a consistent and effective treatment has been difficult.
A team of researchers set out to test a specific strategy to see if they could reverse this damage in a living model. They focused on a therapy called Stempeucel, which combines a mixture of human bone marrow cells with a gel-like substance called hyaluronic acid. The idea was to inject this mixture directly into a damaged disc to see if it could restore the tissue's natural structure and stop the pain. To do this, they first needed a reliable way to create a damaged disc in a laboratory setting that mimicked the human condition. After testing various tools, they determined that a standard 22-gauge needle was the right size to puncture the disc of a rat's lower back. This needle was large enough to cause the necessary injury to simulate degeneration but small enough to avoid causing excessive, uncontrolled damage or leaking the treatment material. They used this method to create a model of disc degeneration in rats, inducing the same kind of tissue breakdown and scarring seen in humans.
Once the injury was established, the researchers divided the animals into different groups to test the therapy. Some rats received no treatment, some received just the gel carrier, and others received the cell therapy at three different strengths: 5 million, 10 million, or 15 million cells. The cells were a special "pooled" mixture, meaning they were gathered from three different healthy human donors and combined. This approach was chosen to ensure the cells worked consistently, rather than relying on cells from just one person, which might vary in quality. The researchers then watched the animals over a period of twelve weeks, checking not only how the discs looked under a microscope but also how the animals moved and felt pain. They measured pain by observing how quickly the rats pulled their tails away from a warm light or how they reacted to gentle pressure on their paws. They also analyzed the animals' walking patterns to see if their coordination improved as the treatment took effect.
The results showed that the treatment worked, particularly when higher doses were used. By the end of the twelve-week study, the rats that received the higher doses of the cell therapy showed a significant reduction in pain and a return to normal walking patterns. When the researchers examined the discs under a microscope, they saw that the treated discs looked much healthier than the untreated ones. The tissue had regained its structure, and the cells inside had begun to produce more of the essential building blocks needed for a healthy disc, such as proteins that hold water and keep the tissue soft. Crucially, the treatment helped reverse the scarring and stiffening that usually happens after an injury. The cells in the treated discs started acting like healthy cartilage cells again, producing the right materials to rebuild the disc's core. In contrast, the discs in the untreated animals remained damaged, with signs of continued scarring and a loss of the healthy gel-like material.
Importantly, the study also looked at whether the treatment caused any harm to the rest of the body. The researchers checked the brains, hearts, lungs, livers, kidneys, and other organs of the treated animals and found no signs of damage or abnormality. The cells stayed where they were injected and did not cause problems elsewhere. This suggests that the therapy is safe and does not trigger toxic reactions in the body. The findings indicate that using a mixture of human cells combined with a supportive gel can help a damaged disc heal itself, restoring its shape and function while reducing pain. While the study was conducted in rats and the researchers note that larger animal models would be needed before this could be tested in people, the results offer a promising path forward. The work demonstrates that it is possible to not just manage the symptoms of a broken disc, but to actually encourage the body to repair the underlying damage, offering hope for a future where lower back pain caused by disc wear might be treated by helping the spine heal itself.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.